MDxHealth S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MDxHealth S.A. with three other
miscellaneous service companies in Europe:
of UNITED KINGDOM
sales of £9.29 million [US$12.34 million]
Evolva Holding SA
(11.60 million Swiss Francs [US$12.71 million]
of which 100%
was Novel Food Nutritional & Pharmaceutical), and
based in GERMANY
(10.63 million Euros [US$12.63 million]
of which 92%
MDxHealth S.A. reported sales of 10.54 million Euro (US$12.52 million)
December of 2019.
decrease of 56.3%
versus 2018, when the company's sales were 24.10 million Euro.